NJ A1136 | 2022-2023 | Regular Session
Note: Carry Foward to future A1322
Note: Carry Over of previous A116
Note: Carry Over of previous S179
Note: Carry Over of previous A116
Note: Carry Over of previous S179
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Introduced, Referred to Assembly Health Committee
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Introduced, Referred to Assembly Health Committee
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.
Title
Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2022-01-11 | Assembly | Introduced, Referred to Assembly Health Committee |
Same As/Similar To
A1136 (Carry Over) 2022-01-11 - Introduced, Referred to Assembly Health Committee
A116 (Carry Over) 2020-01-14 - Introduced, Referred to Assembly Health Committee
S179 (Carry Over) 2020-01-14 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
A116 (Carry Over) 2020-01-14 - Introduced, Referred to Assembly Health Committee
S179 (Carry Over) 2020-01-14 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2022/A1136 |
| Text | https://pub.njleg.gov/Bills/2022/A1500/1136_I1.HTM |
